Expert Series: Dr Chun Fong on finding the keys to unlock AML
Dr Chun Fong believes that testing for minimal residual disease (MRD) is part of the answer.
- Acute myeloid leukaemia
- Interviews with experts
- Research
Category: Research
New trial aimed at keeping people with AML in remission
A new platform trial, a world first, could have transformative implications for people with resistant AML.Â
- Acute myeloid leukaemia
- Clinical trials
Expert Series: Dr Piers Blombery on genomic testing
Dr Piers Blombery explains the basics of molecular testing which informs the treatment of blood cancer. Â
- Hodgkin lymphoma
- Interviews with experts
- Myeloma
- Non-Hodgkin lymphoma
- Research
- Treatments and side-effects
Genomic testing for mutations critical for CLL patients pre-treatment
Dr Piers Blombery specialises in genomic testing and heads Australia’s largest haematology laboratory.Â
- Chronic lymphocytic leukaemia
- Research
International precision medicine clinical trials recruiting
Two new international clinical trials are expected to improve access to new therapies for Australians with MDS as part of the Leukaemia Foundation’s Trials Enabling Program (TEP).
- Clinical trials
- Myelodysplastic syndromes
- Research
Aim of first-ever CMML study – to improve survival
A lot of ‘world firsts’ are involved in an Australian clinical trial that is taking a precision medicine approach to treating CMML, a neglected and serious rare blood cancer that is poorly understood.
- Clinical trials
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
Expert Series: Dr Devendra Hiwase – more research needed for greater insight into MDS
Dr Devendra Hiwase thinks every patient with this rare form of blood cancer should have molecular profiling.
- Interviews with experts
- Myelodysplastic syndromes
Improving infection prevention with drug optimisation
Julian Lindsay’s goal is to set up an international study aimed at improving survival and quality of life through drug optimisation.
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Research
- Treatments and side-effects
Study examines COVID-19 vaccine response in low-grade lymphoma
An Australian study will examine the immune response to the COVID-19 vaccine in patients with the low-grade non-Hodgkin lymphomas.
- Non-Hodgkin lymphoma
- Research
Expert Series: AProf. Michael Dickinson discusses CAR T-cell therapy
Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.
- Acute lymphoblastic leukaemia
- Chronic lymphocytic leukaemia
- Hodgkin lymphoma
- Interviews with experts
- Myeloma
- Non-Hodgkin lymphoma
- Research
- Treatments and side-effects
